MENU
DSGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Design Therapeutics (DSGN) Earnings Date & Reports
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations... Show more
A.I. Advisor
published Earnings
DSGN is expected to report earnings to rise 7.53% to -34 cents per share on November 11
Q3'26
Est.
$-0.34
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.04
The last earnings report on August 03 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 184.75K shares outstanding, the current market capitalization sits at 773.51M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is beta in investing?
What is the meaning of Enterprise Resource Planning (ERP)?
Tesla (TSLA) Stock Analysis: Market Movements, AI Integration, and TSDD Comparison as of June 5, 2025
A Financial Analysis of Top Information Technology Sector Stocks
AI Trading Agent Delivers 207% Annualized Return on AAPL, GOOG, NVDA, TSLA, MSFT, SOXL, SOXS, QID, QLD in 15-Minute Trades
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
6005 Hidden Valley Road
Phone
+1 858 293-4900
Employees
54
Web
https://www.designtx.com